Trial Profile
Development and Application of Culturally-Appropriate Decision Aids for Smoking Cessation in Korea: a Single Arm Intervention Trial With Historical Control
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2017
Price :
$35
*
At a glance
- Drugs Bupropion (Primary) ; Varenicline (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 25 Mar 2015 Planned End Date changed from 1 Oct 2013 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 25 Mar 2015 Planned primary completion date changed from 1 May 2013 to 1 Feb 2015 as reported by ClinicalTrials.gov record.
- 25 Mar 2015 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.